Top

Current Diabetes Reports

Published in:

18-01-2024 | Type 1 Diabetes

A Systematic Review of the Effects of Provider Bias on Health in Youth and Young Adults with Type 1 Diabetes

Authors: Sara E. Wetter-Wren, Alexandra C. Himelhoch, Kimberly A. Driscoll

Published in: Current Diabetes Reports | Issue 3/2024

Abstract

Purpose of Review

Although pervasive inequities in the health outcomes of youth and young adults with type 1 diabetes (T1D) exist, the role of provider bias in these inequities is not well-understood. The purpose of this review is to synthesize evidence from existing studies on the associations between patient characteristics, provider bias, and patient health.

Recent Findings

Fourteen articles were included. Determining the extent of the effects of provider bias on patient health is limited by a lack of consensus on its definition. Experiences of provider bias (e.g., shaming, criticism) negatively affects self-esteem, relationships with medical providers, and depressive symptoms. Provider bias also impacts diabetes technology recommendations, insulin regimen intensity, and risk for life-threatening T1D complications.

Summary

Future studies are needed to develop questionnaires and interviews that better account for diverse experiences and interpretations of bias in T1D healthcare. More research is also needed to investigate mitigating factors to reduce provider bias as a way to improve psychological and physical health in individuals with T1D.

Available only for authorised users

Mulvey A. More people being diagnosed with type 1 diabetes. 2020. https://www.jdrf.org/blog/2020/02/18/more-people-being-diagnosed-type-1-diabetes/. Accessed February 27 2023.

Mayer-Davis EJ, Beyer J, Bell RA, Dabelea D, D’Agostino R Jr, Imperatore G, et al. Diabetes in African American youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009;32 Suppl 2(Suppl 2):S112-22. https://doi.org/10.2337/dc09-S203.CrossRefPubMed

Bell RA, Mayer-Davis EJ, Beyer JW, D’Agostino RB Jr, Lawrence JM, Linder B, et al. Diabetes in non-Hispanic white youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009;32 Suppl 2(Suppl 2):S102-11. https://doi.org/10.2337/dc09-S202.CrossRefPubMed

Delamater AM, Shaw KH, Applegate EB, Pratt IA, Eidson M, Lancelotta GX, et al. Risk for metabolic control problems in minority youth with diabetes. Diabetes Care. 1999;22(5):700–5. https://doi.org/10.2337/diacare.22.5.700.CrossRefPubMed

Gallegos-Macias AR, Macias SR, Kaufman E, Skipper B, Kalishman N. Relationship between glycemic control, ethnicity and socioeconomic status in Hispanic and white non-Hispanic youths with type 1 diabetes mellitus. Pediatr Diabetes. 2003;4(1):19–23. https://doi.org/10.1034/j.1399-5448.2003.00020.x.CrossRefPubMed

Springer D, Dziura J, Tamborlane WV, Steffen AT, Ahern JH, Vincent M, et al. Optimal control of type 1 diabetes mellitus in youth receiving intensive treatment. J Pediatr. 2006;149(2):227–32. https://doi.org/10.1016/j.jpeds.2006.03.052.CrossRefPubMed

Willi SM, Miller KM, DiMeglio LA, Klingensmith GJ, Simmons JH, Tamborlane WV, et al. Racial-ethnic disparities in management and outcomes among children with type 1 diabetes. Pediatrics. 2015;135(3):424–34. https://doi.org/10.1542/peds.2014-1774.CrossRefPubMedPubMedCentral

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40(12):1631–40. https://doi.org/10.2337/dc17-1600.CrossRefPubMedPubMedCentral

Redondo MJ, Libman I, Cheng P, Kollman C, Tosur M, Gal RL, et al. Racial/ethnic minority youth with recent-onset type 1 diabetes have poor prognostic factors. Diabetes Care. 2018;41(5):1017–24. https://doi.org/10.2337/dc17-2335.CrossRefPubMed

10.

Standards of care in diabetes-2023 abridged for primary care providers. Clin Diabetes. 2022;41(1):4–31. https://doi.org/10.2337/cd23-as01.

11.

Lipman TH, Smith JA, Patil O, Willi SM, Hawkes CP. Racial disparities in treatment and outcomes of children with type 1 diabetes. Pediatr Diabetes. 2021;22(2):241–8. https://doi.org/10.1111/pedi.13139.CrossRefPubMed

12.

Auzanneau M, Lanzinger S, Bohn B, Kroschwald P, Kuhnle-Krahl U, Holterhus PM, et al. Area deprivation and regional disparities in treatment and outcome quality of 29,284 pediatric patients with type 1 diabetes in Germany: a cross-sectional multicenter DPV analysis. Diabetes Care. 2018;41(12):2517–25. https://doi.org/10.2337/dc18-0724.CrossRefPubMed

13.

Govan L, Maietti E, Torsney B, Wu O, Briggs A, Colhoun HM, et al. The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetes. Diabetologia. 2012;55(9):2356–60. https://doi.org/10.1007/s00125-012-2601-6.CrossRefPubMedPubMedCentral

14.

Nosek BA, Smyth FL, Hansen JJ, Devos T, Lindner NM, Ranganath KA, et al. Pervasiveness and correlates of implicit attitudes and stereotypes. Eur Rev Soc Psychol. 2007;18(1):36–88.CrossRef

15.

Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc. 2002;94(8):666–8.PubMedPubMedCentral

16.

Green AR, Carney DR, Pallin DJ, Ngo LH, Raymond KL, Iezzoni LI, et al. Implicit bias among physicians and its prediction of thrombolysis decisions for black and white patients. J Gen Intern Med. 2007;22(9):1231–8. https://doi.org/10.1007/s11606-007-0258-5.CrossRefPubMedPubMedCentral

17.

Hausmann LR, Myaskovsky L, Niyonkuru C, Oyster ML, Switzer GE, Burkitt KH, et al. Examining implicit bias of physicians who care for individuals with spinal cord injury: a pilot study and future directions. J Spinal Cord Med. 2015;38(1):102–10. https://doi.org/10.1179/2045772313y.0000000184.

18.

Sabin JA, Greenwald AG. The influence of implicit bias on treatment recommendations for 4 common pediatric conditions: pain, urinary tract infection, attention deficit hyperactivity disorder, and asthma. Am J Public Health. 2012;102(5):988–95. https://doi.org/10.2105/ajph.2011.300621.

19.

Agarwal S, Schechter C, Gonzalez J, Long JA. Racial-ethnic disparities in diabetes technology use among young adults with type 1 diabetes. Diabetes Technol Ther. 2021;23(4):306–13. https://doi.org/10.1089/dia.2020.0338.CrossRefPubMedPubMedCentral

20.

Miller KM, Beck RW, Foster NC, Maahs DM. HbA1c levels in type 1 diabetes from early childhood to older adults: a deeper dive into the influence of technology and socioeconomic status on HbA1c in the T1D exchange clinic registry findings. Diabetes Technol Ther. 2020;22(9):645–50. https://doi.org/10.1089/dia.2019.0393.CrossRefPubMedPubMedCentral

21.

•• Addala A, Hanes S, Naranjo D, Maahs DM, Hood KK. Provider implicit bias impacts pediatric type 1 diabetes technology recommendations in the United States: findings from the Gatekeeper Study. J Diabetes Sci Technol. 2021;15(5):1027–33. An investigation of factors impacting provider recommendations for diabetes technology showed that provider implicit bias significantly impacts T1D treatment recommendations.

22.

Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ, et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care. 2014;37(10):2702–9. https://doi.org/10.2337/dc14-0303.CrossRefPubMedPubMedCentral

23.

Walker AF, Hood KK, Gurka MJ, Filipp SL, Anez-Zabala C, Cuttriss N, et al. Barriers to technology use and endocrinology care for underserved communities with type 1 diabetes. Diabetes Care. 2021;44(7):1480–90. https://doi.org/10.2337/dc20-2753.CrossRefPubMedPubMedCentral

24.

•• Mencher SR, Weinzimer SA, Nally LM, Van Name M, Nunez-Smith M, Sadler LS. Technology utilization in black adolescents with type 1 diabetes: exploring the decision-making process. Diabetes Technol Ther. 2022;24(4):249–57. A qualitative study of factors impacting diabetes technology use in Black adolescents showed medical mistrust and provider misunderstanding of patient culture may impact use of diabetes devices.

25.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71. https://doi.org/10.1136/bmj.n71.CrossRefPubMedPubMedCentral

26.

(CASP) CASP. CASP qualitative studies checklist. n.d. https://casp-uk.net/casp-tools-checklists/. Accessed June 20 2022.

27.

National Heart L, and Blood Institute (NHLBI). Study quality assessment tools. n.d. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed December 9 2019.

28.

Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6. https://doi.org/10.1136/bmj.39489.470347.AD.CrossRefPubMedPubMedCentral

29.

Munn Z, Porritt K, Lockwood C, Aromataris E, Pearson A. Establishing confidence in the output of qualitative research synthesis: the ConQual approach. BMC Med Res Methodol. 2014;14:108. https://doi.org/10.1186/1471-2288-14-108.CrossRefPubMedPubMedCentral

30.

Addala A, Igudesman D, Kahkoska AR, Muntis FR, Souris KJ, Whitaker KJ, et al. The interplay of type 1 diabetes and weight management: a qualitativestudy exploring thematic progression from adolescence to young adulthood. Pediatr Diabetes. 2019;20(7):974–85.CrossRefPubMedPubMedCentral

31.

•• Agarwal S, Crespo-Ramos G, Long JA, Miller VA. “I didn’t really have a choice”: qualitative analysis of racial-ethnic disparities in diabetes technology use among young adults with type 1 diabetes. Diabetes Technol Ther. 2021;23(9):616–22. A qualitative analysis of patient perceptions of T1D technology use revealed exacerbating factors of disparities in pump and CGM use including perceived provider gatekeeping of information about diabetes devices and limited opportunities for shared decision making.

32.

Auslander WF, Thompson SJ, Dreitzer D, Santiago JV. Mothers’ satisfaction with medical care: perceptions of racism, family stress, and medical outcomes in children with diabetes. Health Soc Work. 1997;22(3):190–9.CrossRefPubMed

33.

Crespo-Ramos G, Cumba-Avilés E, Quiles-Jiménez M. “They called me a terrorist”: social and internalized stigma in Latino youth with type 1 diabetes. Health Psychol Rep. 2018;6:307–20.CrossRefPubMed

34.

Haugvik S, Beran D, Klassen P, Hussain A, Haaland A. “My heart burns” – a qualitative study of perceptions and experiences of type 1 diabetes among children and youths in Tajikistan. Chronic Illn. 2017;13:128–39.CrossRefPubMed

35.

Ingersgaard MV, Hoeeg D, Willaing I, Grabowski D. An exploratory study of how young people experience and perceive living with type 1 diabetes during late adolescence and emerging adulthood. Chronic Illn. 2021;17(4):475–92.CrossRefPubMed

36.

Jeong YM, Quinn L, Kim N, Martyn-Nemeth P. Health-related stigma in young adults with type 1 diabetes mellitus. J Psychosoc Nurs Ment Health Serv. 2018;56(10):44–51.CrossRefPubMed

37.

King KM, King PJ, Nayar R, Wilkes S. Perceptions of adolescent patients of the “lived experience” of type 1 diabetes. Diabetes Spectrum. 2017;30(1):23–35.CrossRefPubMedPubMedCentral

38.

Kratzer J. Structural barriers to coping with type 1 diabetes mellitus in Ghana: experiences of diabetic youth and their families. Ghana Med J. 2012;46(2):39–45.PubMedPubMedCentral

39.

•• Montali L, Zulato E, Cornara M, Ausili D, Luciani M. Barriers and facilitators of type 1 diabetes self-care in adolescents and young adults. J Pediatr Nurs. 2022;62:136–43. A qualitative evaluation of barriers and facilitators to T1D self-care revealed provider-level barriers including limited emphasis on psychological well-being and transition from pediatric to adult endocrinology.

40.

Morone JF, Teitelman AM, Cronholm PF, Hawkes CP, Lipman TH. Influence of social determinants of health barriers to family management of type 1 diabetes in Black single parent families: a mixed methods study. Pediatr Diabetes. 2021;22(8):1150–61.CrossRefPubMed

41.

Valenzuela JM, La Greca AM, Hsin O, Taylor C, Delamater AM. Prescribed regimen intensity in diverse youth with type 1 diabetes: role of family and provider perceptions. Pediatr Diabetes. 2011;12(8):696–703.CrossRefPubMed

42.

Dressler WW. Stress and adaptation in the context of culture. New York: State University of New York Press; 1991.

43.

McCubbin HI, Thompson AIE. Family assessment inventories for research and practice. Madison: University of Wisconsin; 1987.

44.

Ware JE Jr, Snyder MK, Wright WR, Davies AR. Defining and measuring patient satisfaction with medical care. Eval Program Plann. 1983;6(3–4):247–63. https://doi.org/10.1016/0149-7189(83)90005-8.CrossRefPubMed

45.

Hanson CL, Henggeler SW, Burghen GA. Model of associations between psychosocial variables and health-outcome measures of adolescents with IDDM. Diabetes Care. 1987;10(6):752–8. https://doi.org/10.2337/diacare.10.6.752.CrossRefPubMed

46.

World Health Organization. Reducing the burden of noncommunicable diseases through strengthening of prevention and control of diabetes. In: Seventy-Fourth World Health Assembly. 2021. https://apps.who.int/gb/ebwha/pdf_files/WHA74-REC1/A74_REC1-en.pdf.

47.

World Health Organization. Mid-point evaluation of the implementation of the WHO global action plan for the prevention and control of noncommunicable diseases 2013–2020. In: Seventy-Fourth World Health Assembly. 2021. https://apps.who.int/gb/ebwha/pdf_files/WHA74-REC1/A74_REC1-en.pdf.

48.

Nguyen LA, Pouwer F, Winterdijk P, Hartman E, Nuboer R, Sas T, et al. Prevalence and course of mood and anxiety disorders, and correlates of symptom severity in adolescents with type 1 diabetes: results from diabetes LEAP. Pediatr Diabetes. 2021;22(4):638–48. https://doi.org/10.1111/pedi.13174.CrossRefPubMedPubMedCentral

49.

Van Tilburg MA, McCaskill CC, Lane JD, Edwards CL, Bethel A, Feinglos MN, et al. Depressed mood is a factor in glycemic control in type 1 diabetes. Psychosom Med. 2001;63(4):551–5. https://doi.org/10.1097/00006842-200107000-00005.CrossRefPubMed

50.

Berger M, Leicht A, Slatcher A, Kraeuter AK, Ketheesan S, Larkins S, et al. Cortisol awakening response and acute stress reactivity in First Nations people. Sci Rep. 2017;7:41760. https://doi.org/10.1038/srep41760.ADSCrossRefPubMedPubMedCentral

51.

Miller GE, Chen E, Zhou ES. If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol Bull. 2007;133(1):25–45. https://doi.org/10.1037/0033-2909.133.1.25.CrossRefPubMed

52.

Ogungbe O, Mitra AK, Roberts JK. A systematic review of implicit bias in health care: a call for intersectionality. IMC J Med Sci. 2019;13(1):005.CrossRef

53.

Govender V, Penn-Kekana L. Gender biases and discrimination: a review of health care interpersonal interactions. Glob Public Health. 2008;3(Suppl 1):90–103. https://doi.org/10.1080/17441690801892208.CrossRefPubMed

54.

American Psychiatric Association. Cultural formulation interview. In: Diagnostic and statistical manual of mental disorders, 5th edn. Arlington, VA. 2013;745–759.

55.

Yudell M, Roberts D, DeSalle R, Tishkoff S, 70 signatories. NIH must confront the use of race in science. Science. 2020;369(6509):1313–4. https://doi.org/10.1126/science.abd4842.

56.

Maghbouleh N, Schachter A, Flores RD. Middle Eastern and North African Americans may not be perceived, nor perceive themselves, to be White. Proc Natl Acad Sci. 2022;119(7):e2117940119. https://doi.org/10.1073/pnas.2117940119.

57.

Divers J, Mayer-Davis EJ, Lawrence JM, Isom S, Dabelea D, Dolan L, et al. Trends in incidence of type 1 and type 2 diabetes among youths - selected counties and Indian reservations, United States, 2002–2015. MMWR Morb Mortal Wkly Rep. 2020;69(6):161–5. https://doi.org/10.15585/mmwr.mm6906a3.CrossRefPubMedPubMedCentral

58.

Health NIo. NIH guidelines on the inclusion of women and minorities as subjects in clinical research. Fed Regist. 1994;59:1408–13.

Title: A Systematic Review of the Effects of Provider Bias on Health in Youth and Young Adults with Type 1 Diabetes
Authors: Sara E. Wetter-Wren
Alexandra C. Himelhoch
Kimberly A. Driscoll
Publication date: 18-01-2024
Publisher: Springer US
Keyword: Type 1 Diabetes
Published in: Current Diabetes Reports / Issue 3/2024
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-023-01527-x

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com